Panos Kavvadas

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Over the last decade, identification and characterization of novel markers of progression and targets for therapy of chronic kidney disease (CKD) have been challenging for the research community. Several promising candidates have emerged, mainly from experimental models of CKD that are yet to be investigated in clinical studies. The authors identified two(More)
  • 1